Artificial intelligence VS COVID-19
Artificial intelligence (also commonly known as AI) is a wide-ranging branch of computer science responsible for building smart machines that are capable of performing tasks that are typically carried out by humans. Artificial intelligence can aid in the recovery from the coronavirus pandemic, an event that has shaped all of our lives for the past six months and will forever change the way that we live our day to day lives.
The COVID-19 pandemic has posed multiple challenges to the artificial intelligence industry, however, it can present many possibilities in the road to recovery.
The innovative technology can be used to track trends and to predict the future of the pandemic, whilst it has not been overly successful so far there is hope in the industry as new technologies arise each day and present their advantages and opportunities. This innovative technology can therefore aid in decision making that can slow the spread of the virus.
Deep learning technology can help to predict old and new drugs, vaccines or treatments that might treat the virus. Several large institutions have already adopted AI so they can identify treatments and develop prototype vaccines in the hope to finally find a treatment. Several companies such as DeepMind have already used deep learning to predict the makeup of proteins associated with SARS-CoV-2.
Throughout the pandemic, false information from inaccurate sources has flooded the internet, to combat this search engines and social media networks are using personalised AI tools that incorporate a specialised algorithm to scan the internet and detect this misinformation, consequently removing it from the internet to prevent the spreading of this false news and reduce fear in the general public.
Artificial intelligence technology could also aid in the early diagnosis of the virus which could then contribute to the studies of how the virus spreads and can allow for the limitation of contamination.
How you can slow the spread of coronavirus:
- Wash your hands with soap and water often – do this for at least 20 seconds
- Use hand sanitiser gel if soap and water are not available
- Wash your hands as soon as you get home
- Cover your mouth and nose with a tissue or your sleeve (not your hands) when you cough or sneeze
- Put used tissues in the bin immediately and wash your hands afterwards
Find out the key information about COVID-19 here.
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”